Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203 La Laguna, Islas Canarias, Tenerife, Spain; Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna, Islas Canarias, Tenerife, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas, Avda. Fco. Sánchez 3, 38206 La Laguna, Islas Canarias, Tenerife, Spain.
Int J Parasitol Drugs Drug Resist. 2024 Apr;24:100531. doi: 10.1016/j.ijpddr.2024.100531. Epub 2024 Mar 6.
Leishmaniasis and Chagas disease are parasitic infections that affect millions of people worldwide, producing thousands of deaths per year. The current treatments against these pathologies are not totally effective and produce some side effects in the patients. Acrylonitrile derivatives are a group of compounds that have shown activity against these two diseases. In this work, four novels synthetic acrylonitriles were evaluated against the intracellular form and extracellular forms of L. amazonensis and T. cruzi. The compounds 2 and 3 demonstrate to have good selectivity indexes against both parasites, specifically the compound 3 against the amastigote form (SI = 6 against L. amazonensis and SI = 7.4 against T. cruzi). In addition, the parasites treated with these two compounds demonstrate to produce a programmed cell death, since they were positive for the events studied related to this type of death, including chromatin condensation, accumulation of reactive oxygen species and alteration of the mitochondrial membrane potential. In conclusion, this work confirms that acrylonitriles is a source of possible new compounds against kinetoplastids, however, more studies are needed to corroborate this activity.
利什曼病和恰加斯病是寄生虫感染,影响着全球数百万人,每年导致数千人死亡。目前针对这些疾病的治疗方法并不完全有效,并且会在患者身上产生一些副作用。丙烯腈衍生物是一类对这两种疾病都具有活性的化合物。在这项工作中,四种新型合成丙烯腈化合物针对 L. amazonensis 和 T. cruzi 的细胞内形式和细胞外形式进行了评估。化合物 2 和 3 对两种寄生虫均显示出良好的选择性指数,特别是化合物 3 对无鞭毛体形式(对 L. amazonensis 的 SI = 6,对 T. cruzi 的 SI = 7.4)。此外,用这两种化合物处理的寄生虫表现出程序性细胞死亡,因为它们对与这种类型的死亡相关的研究事件呈阳性,包括染色质浓缩、活性氧物质的积累和线粒体膜电位的改变。总之,这项工作证实丙烯腈是针对动基体目寄生虫的可能新化合物的来源,但需要进一步的研究来证实这种活性。